- Home
- EPAM vs LNTH Comparison
EPAM vs LNTH Comparison
Compare EPAM & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAM
- LNTH
- Stock Information
- Founded
- EPAM 1993
- LNTH 1956
- Country
- EPAM United States
- LNTH United States
- Employees
- EPAM N/A
- LNTH N/A
- Industry
- EPAM EDP Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EPAM Technology
- LNTH Health Care
- Exchange
- EPAM Nasdaq
- LNTH Nasdaq
- Market Cap
- EPAM 8.9B
- LNTH 3.8B
- IPO Year
- EPAM 2012
- LNTH 2015
- Fundamental
- Price
- EPAM $174.24
- LNTH $51.19
- Analyst Decision
- EPAM Buy
- LNTH Buy
- Analyst Count
- EPAM 14
- LNTH 6
- Target Price
- EPAM $221.36
- LNTH $74.50
- AVG Volume (30 Days)
- EPAM 807.9K
- LNTH 1.4M
- Earning Date
- EPAM 11-06-2025
- LNTH 11-06-2025
- Dividend Yield
- EPAM N/A
- LNTH N/A
- EPS Growth
- EPAM N/A
- LNTH N/A
- EPS
- EPAM 6.55
- LNTH 2.39
- Revenue
- EPAM $5,297,859,000.00
- LNTH $1,525,933,000.00
- Revenue This Year
- EPAM $16.65
- LNTH N/A
- Revenue Next Year
- EPAM $7.20
- LNTH $1.98
- P/E Ratio
- EPAM $26.76
- LNTH $21.34
- Revenue Growth
- EPAM 14.26
- LNTH 1.95
- 52 Week Low
- EPAM $138.15
- LNTH $47.25
- 52 Week High
- EPAM $269.00
- LNTH $111.29
- Technical
- Relative Strength Index (RSI)
- EPAM 69.17
- LNTH 36.35
- Support Level
- EPAM $155.00
- LNTH $54.76
- Resistance Level
- EPAM $164.00
- LNTH $61.92
- Average True Range (ATR)
- EPAM 6.20
- LNTH 2.36
- MACD
- EPAM 1.92
- LNTH -0.44
- Stochastic Oscillator
- EPAM 97.95
- LNTH 4.15
About EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.